NEW Enterprise Associates 13 L.P. is 10% Owner at Epizyme, Inc. (EPZM). They have made 10 open-market trades across 8 companies since 2012, most recently 2024-01-29.
7 open-market purchases totalling $54.8M since 2012, against 3 sales. Across 6 scored buys the stock is down 7.9% at ninety days, and 7.3 points behind the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 17% | 33% | 33% |
| Avg Move | -20.8% | -4.7% | -7.9% |
| Alpha | -39.6% | -5.3% | -7.3% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PHAS | SELL | 2022-10-25 | 2022-10-26 | $0.15 | $535K | N/A | N/A | N/A |
| UTRS | BUY | 2021-10-26 | 2021-10-28 | $12.00 | $15.6M | +7.6% | -28.9% | -48.2% |
| DERM | BUY | 2014-10-08 | 2014-10-08 | $16.00 | $1.1M | -5.7% | +9.2% | +9.2% |
| CVT | SELL | 2014-01-21 | 2014-01-23 | $35.50 | $6.0M | -11.1% | -2.5% | -2.5% |
| GLYC | BUY | 2014-01-15 | 2014-01-15 | $8.00 | $4.1M | -22.0% | +1.1% | +1.1% |
| EPZM | BUY | 2013-11-14 | 2013-11-18 | $19.68 | $8.0M | -37.3% | -2.4% | -2.4% |
| EPZM | BUY | 2013-06-05 | 2013-06-07 | $15.00 | $6.0M | -37.3% | -2.4% | -2.4% |
| OMTH | BUY | 2013-04-16 | 2013-04-17 | $8.00 | $5.0M | N/A | N/A | N/A |
| OMTH | SELL | 2013-04-16 | 2013-04-17 | $8.00 | $2K | N/A | N/A | N/A |
| TSRO | BUY | 2012-07-03 | 2012-07-03 | $13.50 | $15.0M | -30.2% | -4.9% | -4.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| CRCM | 2,256,013 | $33.8M |
| SGMT | 3,000,275 | $24.1M |
| DERM | 3,502,922 | $17.4M |
| EPZM | 5,854,351 | $8.6M |
| UTRS | 596,183 | $882K |
| GLYC | 3,580,877 | $562K |
| PHAS | 4,857,525 | $341K |
| CLVS | 2,279,781 | $185K |
| OMTH | 156,054 | — |
| Total | $2.4B |
Shares reported on the most recent Form 4, priced at the 2024-01-31 close. 1 holding could not be priced and is excluded from the total.